Physician profile
Robert J Dimitriou
NPI 1932163763
$12,252.43
in general payments reported to CMS, 2019-2025
58 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,504 · 2020: $1,124 · 2021: $1,576 · 2022: $2,077 · 2023: $2,526 · 2024: $1,980 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,110 · Travel and Lodging: $630 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,110.26 |
| Travel and Lodging | $630.46 |
| Education | $229.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,643.13 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,625.91 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $797.89 | 2019-2025 | Xtandi, Myrbetriq |
| Coloplast Corp | $745.00 | 2019-2024 | Altis, Speedicath |
| Abbvie INC. | $601.27 | 2019-2025 | Lupron Depot |
| Janssen Biotech, INC. | $576.47 | 2020-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $487.18 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic USA, INC. | $482.93 | 2019-2020 | |
| Boston Scientific Corporation | $451.40 | 2019-2025 | Ams 700, Rezum Generator |
| Dendreon Pharmaceuticals LLC | $354.71 | 2021-2025 | Provenge |
| Pfizer INC. | $308.01 | 2019-2025 | |
| Antares Pharma, INC. | $292.35 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| C. R. Bard, INC. & Subsidiaries | $239.42 | 2020-2025 | Personal Catheter Intermittent Catheter, Purewick Female External Catheter |
| Procept Biorobotics Corporation | $227.36 | 2019-2025 | Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $200.43 | 2022-2025 | Prolaris |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dimitriou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.